Overview

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn how breast cancer tumors respond to treatment combining the drugs docetaxel and ZD1839.
Phase:
Phase 2
Details
Lead Sponsor:
NSABP Foundation Inc
Collaborator:
AstraZeneca
Treatments:
Docetaxel
Gefitinib